Navigation Links
Thrombosis, a Serious Risk in Children with Leukemia

Thrombosis is a serious complication that can occur in children affected by acute lymphoblastic leukemia and can in turn lead to heart attack, pulmonary embolism and other cardiovascular diseases//.

It is the result of a research performed in Italy by the Laboratory of Genetic and Environmental Epidemiology and the Onco-Haematology Unit of the Catholic University in collaboration with the Haematology Division of the University of L'Aquila.

Thrombosis in children with leukaemia is a serious problem, that adds a new clinical concern for these children already troubled by such a severe disease. Prevention and focused therapy are essential in order to avoid complications that may turn out to be extremely harsh. What is the frequency with which thrombosis occurs in these young patients? Which role do their genetic characteristics play and which kind of therapy are they submitted to? The study used metanalytic techniques, a complex statistic procedure that, by combining and analysing data published by several international research teams, allowed the researchers to determine in a very precise way the association between ALL and thrombotic complications in 1,752 children affected by this type of leukaemia.

Data were taken from 17 international studies selected according to strict scientific criteria. In 5,2 percent of the children thrombotic complications were reported. Researchers have been able to identify several factors involved in determining the risk for this complication. Particularly, many of the thrombotic events occurred during the so called 'induction' phase of the antileukaemic therapy. Moreover, the researchers successfully identified therapies and medical procedures mainly associated with the risk of thrombosis. Finally, the possible role of genetic determinants (especially the hereditary tendency for excessive blood coagulation, called thrombophilia) was explored.

"The risk of these complications – says Maria Benedet ta Donati, Scientific Projects Coordinator at the Research Laboratories of the Catholic University - is relatively high and the analysis of the affected children's characteristics allowed us to identify those at high risk. In this way, data will be immediately available for haematologists in order to decide the best therapies to undertake, also according to the genetic predisposition of each individual child".

Source: Eurekaler
'"/>




Related medicine news :

1. Socialization A Serious Trouble For Childhood Cancer Survivors
2. Viagra May Be Useful For Serious Lung Disease
3. Mountain Biking Results In Serious Injuries
4. Breast Cancer More Serious For Younger Patients
5. Rahul Mahajans Condition Is Serious But Stable : Hospital
6. Africans Should Take Their Traditional Medicine Very Seriously
7. Electronic Patient Record "Serious Threat" to Patient Confidentiality
8. "Serious Failings" Led To Spread Of Lethal Hospital Bug
9. Scottish Children Attracted To Serious Gambling
10. Government Views Cola Contamination with Utmost Seriousness: Anbumani
11. Callous Thieves Rob An Seriously Ill Child Of His Vital Heart Machine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the ... today its plans to open a flagship location in Covington, LA at 401 N. ... To Go store next to Office Depot in the Holiday Square shopping center. Its ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology: